Beso Davitashvili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Beso Davitashvili has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alan David Kaye
Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA
1 shared publication - Hisham Turjman
School of Medicine, Royal College of Surgeons in Ireland, Baharain, USA
1 shared publication - Jayshil Patel
Benchmark Physical Therapy, Upstream Rehabilitation, Knoxville, USA
1 shared publication - Jeremiah Hilkiah Wijaya
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
1 shared publication - Kevin Yabut
Louisiana State University Health Sciences Center, Shreveport, USA
1 shared publication - Made Agus Mahendra Inggas
Department of Neurosurgery, Universitas Pelita Harapan, Tangerang, Indonesia
1 shared publication
Latest Publications
- 22 January 2025
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 29 (1) , 1-12
A Systematic Review and Meta-Analysis of Stem Cell Therapies for Pain in Diabetic Neuropathy, Osteoarthritis, and Spinal Cord Injuries
Purpose of Review The use of stem cell therapy is a rapidly evolving and progressing frontier of science that has been used to treat illnesses such as malignancies, immunodeficiencies, and metabolic syndromes. This review aims to give an overview of the use of stem cell therapy in the treatment of pain caused by diabetic neuropathy, osteoarthritis, and other spinal cord pathologies. Recent Findings Pain is defined as a generalized or localized feeling of distress related to a physical or emotional stimulus and can be caused by a multitude of pathologies. The field of pain management has explored many strategies such as gene therapies, neuromodulation, platelet-rich plasma, and numerous pharmacotherapies. The approach to the delivery of these strategies has varied, with the method of stem cell therapy delivery being the focus of this present investigation. In addition, we combined several different studies to analyze the effects of stem cell therapies and improvement in pain scores quantified by the visual analog scale (VAS). The overall results showed a mean difference of -2.58, suggesting that the stem cell treatment group had a lower VAS score at 6 months compared to the control group. Summary The use of different types of stem cells, such as pluripotent and mesenchymal stem cells, play a critical role in the care of cases suffering from pain. Effective delivery methods are evolving and can transform treatment options in the future, for which large cohort studies are warranted.
- 22 January 2025
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 29 (1) , 1-12
A Systematic Review and Meta-Analysis of Stem Cell Therapies for Pain in Diabetic Neuropathy, Osteoarthritis, and Spinal Cord Injuries
Purpose of Review The use of stem cell therapy is a rapidly evolving and progressing frontier of science that has been used to treat illnesses such as malignancies, immunodeficiencies, and metabolic syndromes. This review aims to give an overview of the use of stem cell therapy in the treatment of pain caused by diabetic neuropathy, osteoarthritis, and other spinal cord pathologies. Recent Findings Pain is defined as a generalized or localized feeling of distress related to a physical or emotional stimulus and can be caused by a multitude of pathologies. The field of pain management has explored many strategies such as gene therapies, neuromodulation, platelet-rich plasma, and numerous pharmacotherapies. The approach to the delivery of these strategies has varied, with the method of stem cell therapy delivery being the focus of this present investigation. In addition, we combined several different studies to analyze the effects of stem cell therapies and improvement in pain scores quantified by the visual analog scale (VAS). The overall results showed a mean difference of -2.58, suggesting that the stem cell treatment group had a lower VAS score at 6 months compared to the control group. Summary The use of different types of stem cells, such as pluripotent and mesenchymal stem cells, play a critical role in the care of cases suffering from pain. Effective delivery methods are evolving and can transform treatment options in the future, for which large cohort studies are warranted.